Stephen Ting

Adj ClinAssProf


Research activity per year

If you made any changes in Pure these will be visible here soon.

Personal profile


Stephen Ting is a Haematology clinician-scientist based at Alfred Health-Monash University. He is an active practising haematologist and a principal investigator studying self-renewal pathways of haematopoeitic and leukemia stem cells.

Stephen Ting is a Haematology clinician scientist. He completed his medical training in clinical and laboratory haematology at Monash University and affiliated hospitals in 1998. He was awarded postgraduate scholarships by the HSANZ to study Polycythemia in Hopital Cochin, Paris (1999) and Cancer Council of Victoria to undertake PhD studies with Professor Stephen Jane at the Bone Marrow Research Laboratories (2000-2005) where his discoveries of the Grhl3 gene earned him numerous awards, including the Victorian Premier's Award in Medical Research (2005). Stephen obtained NHMRC CJ Martin, Canadian Post-Doctoral and RACP Bushell Travelling Fellowships to pursue further studies with Professor Guy Sauvageau in Montreal, Canada (2006-2009) investigating self-renewal mechanisms in hematopoietic stem cells. In 2010, he returned to Peter MacCallum Cancer Centre, as a senior Research Fellow and in mid-2011, was appointed as a group leader in the Division of Blood Cancers, ACBD to continue his independent research that identifies the importance of asymmetric cell division within both haematopoietic and leukemia stem cells.

Dr Ting's research has thus far received $1.5 million from funding bodies that include, the NHMRC, Cancer Council of Victoria, Leukaemia Foundation and RACP. His work has been published in high impact journals including Science, Nature Medicine, Cell, Cell Stem Cell, Developmental Cell, and Blood.

Research interests

The research focus of Dr Ting aims to understand the molecular mechanisms governing haematopoietic and leukemia stem cell self-renewal. Using a functional screen he has identified novel endocytosis and cytoskeleton genes that enhance HSC activity. And via live cell videomicroscopy established Ap2a2 as an asymmetrically segregating protein in HSCs, thereby linking asymmetric cell division (ACD) to HSC self-renewal. He will utilise these discoveries to interrogate the fate and gene expression of daughter cells from ACD of HSCs. These genes shall also be studied for ex-vivo HSC expansion properties and whether their perturbation alters leukemia outcome in mouse models.

  • Investigating asymmetric cell division in HSCs
  • The mitotic spindle during haematopoietic and leukemia stem cell self-renewal
  • The role of the cytoskeleton gene, Kif3 in ACD and T-ALL
  • Ex vivo expansion of HSCs for transplantation

Monash teaching commitment

Lecturer in Human Pathology and Clinical Science courses

Community service

6 months studying Mandarin in China at the Beijing Language and Cultural University.
2 months on Thailand-Myanmar border as a volunteer doctor

2013 - present

Leukemia Foundation: speaker at annual patient information symposiums

Clinical activities

Consultant haematologist at Alfred Hospital, Melbourne, Victoria with inpatient and outpatient duties.

VMO consultant haematologist at Cabrini Hospital, Malvern, Victoria.

Expertise related to UN Sustainable Development Goals

In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):

  • SDG 3 - Good Health and Well-being

Research area keywords

  • Ap2a2
  • HSC
  • Asymmetric Cell Division
  • HSC self-renewal
  • Biomedical Research, Multidisciplinary
  • Blood Diseases
  • Cancer
  • Grhl3
  • curly tail
  • grainy head
  • neural tube closure
  • wound closure
  • epithelial morphogenesis
  • Hematology
  • Stem Cell

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or